Spinocerebellar ataxia type 17 mutation as a causative and susceptibility gene in parkinsonism

Neurology

Volumn 72, Issue 16, 2009, Pages 1385-1389

  Kim, J Y ^a,b   Kim, S Y ^a,b   Kim, J M ^b,c   Kim, Y K ^b,c   Yoon, K Y ^a,b   Lee, B C ^b,c   Kim, J S ^b,c   Paek, S H ^a,b   Park, S S ^a,b   Kim, S E ^b,c   Jeon, B S ^a,b  

^a Seoul National University Hospital   (South Korea)

^b Seoul National University   (South Korea)

^c Bundang Hospital   (South Korea)

Author keywords

[No Author keywords available]

Indexed keywords

ATAXIN 1; DOPAMINE TRANSPORTER; LEVODOPA; SPINOCEREBELLAR ATAXIA 17 PROTEIN; UNCLASSIFIED DRUG; [2 [[2 [[[3 (4 CHLOROPHENYL) 8 METHYL 8 AZABICYCLO[3.2.1]OCT 2 YL]METHYL](2 MERCAPTOETHYL)AMINO]ETHYL]AMINO]ETHANETHIOLATO]OXOTECHNETIUM TC 99M; BIOLOGICAL MARKER; DIAGNOSTIC AGENT; TATA BINDING PROTEIN; TBP PROTEIN, HUMAN; TECHNETIUM COMPLEX; TECHNETIUM TC 99M TRODAT 1; TECHNETIUM TC 99M TRODAT-1; TROPANE DERIVATIVE;

ADULT; AGED; ARTICLE; CONTROLLED STUDY; FEMALE; GENE; GENE MUTATION; GENETIC SUSCEPTIBILITY; HUMAN; MAJOR CLINICAL STUDY; MALE; PARKINSON DISEASE; PARKINSONISM; PENETRANCE; PHENOTYPE; PRIORITY JOURNAL; PROTEIN BINDING; SCA17 GENE; SHY DRAGER SYNDROME; SINGLE PHOTON EMISSION COMPUTER TOMOGRAPHY; SOUTH KOREA; SPINOCEREBELLAR ATAXIA TYPE 17; SPINOCEREBELLAR DEGENERATION; TRINUCLEOTIDE REPEAT; CORPUS STRIATUM; GENE FREQUENCY; GENETIC PREDISPOSITION; GENETIC SCREENING; GENETICS; GENOTYPE; METABOLISM; METHODOLOGY; MIDDLE AGED; MUTATION; NUCLEOTIDE SEQUENCE; PATHOPHYSIOLOGY; PREDICTION AND FORECASTING; SCINTISCANNING; SUBSTANTIA NIGRA;

AGED; BIOLOGICAL MARKERS; CORPUS STRIATUM; DNA MUTATIONAL ANALYSIS; DOPAMINE PLASMA MEMBRANE TRANSPORT PROTEINS; FEMALE; GENE FREQUENCY; GENETIC PREDISPOSITION TO DISEASE; GENETIC SCREENING; GENOTYPE; HUMANS; MALE; MIDDLE AGED; MULTIPLE SYSTEM ATROPHY; MUTATION; ORGANOTECHNETIUM COMPOUNDS; PARKINSONIAN DISORDERS; PREDICTIVE VALUE OF TESTS; SUBSTANTIA NIGRA; TATA-BOX BINDING PROTEIN; TOMOGRAPHY, EMISSION-COMPUTED, SINGLE-PHOTON; TROPANES;

EID: 67449136057     PISSN: 00283878     EISSN: 1526632X     Source Type: Journal    
DOI: 10.1212/WNL.0b013e3181a18876     Document Type: Article

References (14)

1. Koide R, Kobayashi S, Shimohata T, et al. A neurological disease caused by an expanded CAG trinucleotide repeat in the TATA-binding protein gene: a new polyglutamine disease? HumMol Genet 1999;8:2047-2053.
2. Schols L, Bauer P, Schmidt T, Schulte T, Riess O. Autosomal dominant cerebellar ataxias: clinical features, genetics, and pathogenesis. Lancet Neurol 2004;3:291-304.
3. Bauer P, Laccone F, Rolfs A, et al. Trinucleotide repeat expansion in SCA17/TBP in white patients with Huntington's disease-like phenotype. J Med Genet 2004;41:230-232.
4. Oda M, Maruyama H, Komure O, et al. Possible reduced penetrance of expansion of 44 to 47 CAG/CAA repeats in the TATA-binding protein gene in spinocerebellar Ataxia Type 17. Arch Neurol 2004;61:209-212.
5. Wu YR, Lin HY, Chen CM, et al. Genetic testing in spinocerebellar ataxia in Taiwan: expansions of trinucleotide repeats in SCA8 and SCA17 are associated with typical Parkinson's disease. Clin Genet 2004;65:209-214.
6. Lin IS, Wu RM, Lee-Chen GJ, Shan DE, Gwinn-Hardy K. The SCA17 phenotype can include features of MSA-C, PSP and cognitive impairment. Parkinsonism Relat Disord 2007;13:246-249.
7. Gwinn-Hardy K, Singleton A, O'Suilleabhain P, et al. Spinocerebellar ataxia type 3 phenotypically resembling Parkinson disease in a black family. Arch Neurol 2001;58: 296-299.
8. Kim JM, Hong S, Kim GP, et al. Importance of low-range CAG expansion and CAA interruption in SCA2 Parkinsonism. Arch Neurol 2007;64:1510-1518.
9. Minnerop M, Joe A, Lutz M, et al. Putamen dopamine transporter and glucose metabolism are reduced in SCA17. Ann Neurol 2005;58:490-491.
10. Rolfs A, Koeppen AH, Bauer I, et al. Clinical features and neuropathology of autosomal dominant spinocerebellar ataxia (SCA17). Ann Neurol 2003;54:367-375.
11. Nakamura K, Jeong SY, Uchihara T, et al. SCA17, a novel autosomal dominant cerebellar ataxia caused by an expanded polyglutamine in TATA-binding protein. Hum Mol Genet 2001;10:1441-1448.
12. Rasmussen A, De Blase I, Fragoso-Benítez M, et al. Anticipation and intergenerational repeat instability in spinocerebellar ataxia type 17. Ann Neurol 2007;61:607-610.
13. Ahn TB, Kim SY, Kim JY, et al. α-Synuclein gene duplication is present in sporadic Parkinson disease. Neurology 2008;70:43-49.
14. Nanda A, Jackson SA, Schwankhaus JD, Metzer WS. Case of spinocerebellar ataxia type 17 (SCA17) associated with only 41 repeats of the TATA-binding protein (TBP) gene. Mov Disord 2007;22:436.